April 20, 2023
Cell Therapy Analytics: Overcoming CMC Challenges at Cambridge Healthtech Institute

Farnaz @farnaznasreen

The complexity and rapid growth of autologous and allogeneic cell therapies presents significant new CMC challenges companies must address and overcome. Our experts share their personal experiences an…

May 25, 2023

Farnaz @farnaznasreen

Developing and engineering recombinant protein expression platforms are not for the faint of heart. Many variables must be considered during the development process. When cell line challenges arise, s…

June 29, 2023

Farnaz @farnaznasreen

Newer and more complex molecules often complicate existing downstream processes. New, innovative technologies are necessary to ensure safe, efficient, and effective capture and purification of emergin…

September 21, 2023

Farnaz @farnaznasreen

PRESENTED BY EVALUATING BIOPHARMA
Advances in manufacturing 4.0 including digitalization, AI, and machine learning offer biopharmaceutical company’s unique opportunities to overhaul antiquated proces…

October 19, 2023
Evaluating Biopharma: Continuous Bioprocessing at Cambridge Healthtech Institute

Farnaz @farnaznasreen

PRESENTED BY EVALUATING BIOPHARMA
With competition heating up, companies are now looking at cost savings. Process intensification and optimization via continuous processing fills this urgent need. Ho…